{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O14793",
      "entity_text" : "myostatin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0564" ],
      "Organ" : [ "uaz:UA-ORG-92" ]
    }
  },
  "verbose_text" : "Our in vivo results further confirmed that repeated subcutaneous injections of the nanoparticles loaded with a low dose of FS-344 mRNA (0.5 mg/kg) provide sustained and robust production of secreted FS-315 that is capable of decreasing serum levels of both myostatin and activin A, thereby increasing muscle mass in 17-week-old C57BL/6L mice.",
  "reading_complete" : "2020-08-03T16:49:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:47:37Z",
  "trigger" : "levels",
  "evidence" : [ "levels of both myostatin" ],
  "pmc_id" : "6276093",
  "score" : 0
}